Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior

Journal of Psychopharmacology

Volumn 26, Issue 7, 2012, Pages 982-993

  Gowin, Joshua L ^a   Green, Charles E ^b   Alcorn, Joseph L ^a   Swann, Alan C ^a,b   Moeller, F Gerard ^a,b   Lane, Scott D ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

GABA; human aggression; PSAP; tiagabine

Indexed keywords

PLACEBO; TIAGABINE;

ADULT; AGGRESSION; ANTISOCIAL BEHAVIOR; BEHAVIOR DISORDER; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG RESPONSE; EVENING DOSAGE; FEMALE; HUMAN; MALE; MORNING DOSAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; REVIEW; SUBSTANCE ABUSE; TIME; VIOLENCE;

ADULT; AGGRESSION; ANTICONVULSANTS; ANTISOCIAL PERSONALITY DISORDER; BAYES THEOREM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GABA UPTAKE INHIBITORS; HUMANS; IMPULSIVE BEHAVIOR; MALE; NIPECOTIC ACIDS; PATIENT DROPOUTS; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE-RELATED DISORDERS; TEXAS; TIME FACTORS; VIOLENCE; YOUNG ADULT;

EID: 84862886360     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111408962     Document Type: Review

References (68)

1. Arseneault L, Moffitt TE, Caspi A, Taylor PJ, Silva PA. Mental disorders and violence in a total birth cohort: results from the Dunedin Study. Arch Gen Psychiatry. 2000; 57: 979-986
2. Barratt ES, Stanford MS, Felthous AR, Kent TA. The effects of phenytoin on impulsive and premeditated aggression: a controlled study. J Clin Psychopharmacol. 1997; 17: 341-349 (Pubitemid 27414389)
3. Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E, Fisher S, et al. A genome-wide association study of alcohol dependence. Proc Natl Acad Sci U S A. 2010; 107: 5082-5087
4. Bjork JM, Moeller FG, Kramer GL, Kram M, Suris A, Rush AJ, et al. Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder. Psychiatry Res. 2001; 101: 131-136 (Pubitemid 32245796)
5. Braga MF, Aroniadou-Anderjaska V, Li H, Rogawski MA. Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons. J Pharmacol Exp Ther. 2009; 330: 558-566
6. Browne WJ MCMC Estimation in MlwiN. University of Bristol: Bristol, UK: Centre for Multilevel Modelling; 2009 :
7. Buss AH, Perry M. The Aggression Questionnaire. J Pers Soc Psychology. 1992; 63: 452-459
8. Cherek DR, Lane SD. Laboratory and psychometric measurements of impulsivity among violent and nonviolent female parolees. Biol Psychiatry. 1999; 46: 273-280 (Pubitemid 29320080)
9. Cherek DR, Lane SD. Acute effects of d-fenfluramine on simultaneous measures of aggressive, escape and impulsive responses of adult males with and without a history of conduct disorder. Psychopharmacology. 2001; 157: 221-227 (Pubitemid 32905562)
10. Cherek DR, Lane SD, Pietras CJ Aggression: Assessment and Treatment. Coccaro EF, ed. New York: Marcel Dekker; 2003 :
11. Cherek DR, Lane SD, Pietras CJ, Steinberg JL. Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder. Psychopharmacology (Berl). 2002; 159: 266-274 (Pubitemid 34143375)
12. Cherek DR, Spiga R, Egli M. Effects of response requirement and alcohol on human aggressive responding. J Exp Anal Behav. 1992; 58: 577-587
13. Cherek DR, Tcheremissine OV, Lane SD, Pietras CJ. Acute effects of gabapentin on laboratory measures of aggressive and escape responses of adult parolees with and without a history of conduct disorder. Psychopharmacology (Berl). 2004; 171: 405-412 (Pubitemid 38200052)
14. Coccaro EF, Berman ME, Kavoussi RJ. Assessment of life history aggression: development and psychometric characteristics. Psychiatry Res. 1997; 73: 147-157 (Pubitemid 28088171)
15. Cramer JA, Mintzer S, Wheless J, Mattson RH. Adverse effects of antiepileptic drugs: a brief overview of important issues. Expert Rev Neurother. 2010; 10: 885-891
16. De Almeida RM, Ferrari PF, Parmigiani S, Miczek KA. Escalated aggressive behavior: dopamine, serotonin and GABA. Eur J Pharmacol. 2005; 526: 51-64 (Pubitemid 41744105)
17. Earley CJ, Leonard BE. The effect of testosterone and cyproterone acetate on the concentration of gamma-aminobutyric acid in brain areas of aggressive and non-aggressive mice. Pharmacol Biochem Behav. 1977; 6: 409-413 (Pubitemid 8128325)
18. Edenberg HJ, Foroud T. Review: The genetics of alcoholism: identifying specific genes through family studies. Addict Biol. 2006; 11: 386-396 (Pubitemid 46696910)
19. Enoch MA, Hodgkinson CA, Yuan Q, Shen PH, Goldman D, Roy A. The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence. Biol Psychiatry. 2010; 67: 20-27
20. Eysenck HJ, Barrett P, Eysenck SB. Indices of factor comparison for homologous and non-homologous personality scales in 24 different countries. Pers Individ Dif. 1985; 6: 503-505
21. First MB, Spitzer RL, Gibbon M, Williams JBW Structured Clinical Interview for DSM-IV Axis I Disorders: Non patient edition (SCID-NP). New York: NY State Psychiatric Institute; 1996 :
22. First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin LS Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II). Washington, DC: American Psychiatric Press, Inc; 1997 :
23. Gill J Bayesian Methods: A Social and Behavioral Sciences Approach. Boca Raton, FL: Chapman & Hall/CRC; 2002 :
24. González G, Desai R, Sofuoglu M, Poling J, Oliveto A, Gonsai K, et al. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 2007; 87: 1-9 (Pubitemid 46074378)
25. Gourley SL, Debold JF, Yin W, Cook J, Miczek KA. Benzodiazepines and heightened aggressive behavior in rats: reduction by Gaba(A)/Alpha(1) receptor antagonists. Psychopharmacology (Berl). 2005; 178: 232-240 (Pubitemid 40379218)
26. Griffith JL. Treatment of episodic behavioral disorders with rapidly absorbed benzodiazepines. J Nerv Ment Dis. 1985; 173: 312-315 (Pubitemid 15040395)
27. Guay DR. Newer antiepileptic drugs in the management of agitation/aggression in patients with dementia or developmental disability. Consult Pharm. 2007; 22: 1004-1034 (Pubitemid 350291261)
28. Hellings JA, Weckbaugh M, Nickel EJ, Cain SE, Zarcone JR, Reese RM, et al. A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2005; 15: 682-692 (Pubitemid 41434372)
29. Hoffman DA. Tiagabine for rage, aggression, and anxiety. JNeuropsychiatry Clin Neurosci. 2005; 17: 252
30. Hollander ES, Swann AC, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex versus placebo in borderline personality disorder. Am J Psychiatry. 2005; 162: 621-624 (Pubitemid 40343936)
31. Hollander E, Tracy KA, Swann AC, Coccaro EF, Mcelroy SL, Wozniak P, et al. Divalproex in the treatment of impulsive aggression: efficacy in Cluster B personality disorders. Neuropsychopharmacology. 2003; 28: 1186-1197
32. Huband N, Ferriter M, Nathan R, Jones H. Antiepileptics for aggression and associated impulsivity. Cochrane Database Syst Rev. 2010; 2 :
33. Kaufman KR, Kugler SL, Sachdeo RC. Tiagabine in the management of postencephalitic epilepsy and impulse control. Epilepsy Behav. 2002; 3: 190-194
34. Kessler RC, Coccaro EF, Fava M, Jaeger S, Jin R, Walters E. The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2006; 63: 669-678 (Pubitemid 43848298)
35. Khalifa N, Duggan C, Stoffers J, Huband N, Vollm BA, Ferriter M, et al. Pharmacological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2010; 8 :
36. Kim E. The use of newer anticonvulsants in neuropsychiatric disorders. Curr Psychiatry Rep. 2002; 4: 331-337
37. Lane SD, Gowin JL, Green CE, Steinberg JL, Moeller FG, Cherek DR. Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior. Pharmacol Biochem Behav. 2009; 92: 357-362
38. Lane SD, Steinberg JL, Ma L, Hasan KM, Kramer LA, Zuniga EA, et al. Diffusion tensor imaging and decision making in cocaine dependence. PLoS One. 2010; 5: e11591
39. Lee R, Petty F, Coccaro EF. Cerebrospinal fluid GABA concentration: relationship with impulsivity and history of suicidal behavior, but not aggression, in human subjects. JPsychiatr Res. 2009; 43: 353-359
40. Lieving LM, Cherek DR, Lane SD, Tcheremissine OV, Nouvion SO. Effects of acute tiagabine administration on aggressive responses of adult male parolees. J Psychopharmacol. 2008; 22: 144-152 (Pubitemid 351322863)
41. Malcolm RJ. GABA systems, benzodiazepines, and substance dependence. J Clin Psychiatry. 2003; 64 (Suppl 3). 36-40 (Pubitemid 36389870)
42. Miczek KA, De Almeida RM, Kravitz EA, Rissman EF, de Boer SF, Raine A. Neurobiology of escalated aggression and violence. J Neurosci. 2007; 27: 11803-11806 (Pubitemid 350072089)
43. Miczek KA, Faccidomo S, De Almeida RM, Bannai M, Fish EW, Debold JF. Escalated aggressive behavior: new pharmacotherapeutic approaches and opportunities. Ann N Y Acad Sci. 2004; 1036: 336-355 (Pubitemid 40576105)
44. Miczek KA, Fish EW, De Bold JF. Neurosteroids, GABAA receptors, and escalated aggressive behavior. Horm Behav. 2003; 44: 242-257 (Pubitemid 37371979)
45. Moeller FG, Dougherty DM, Lane SD, Steinberg JL, Cherek DR. Antisocial personality disorder and alcohol-induced aggression. Alcohol Clin Exp Res. 1998; 22: 1898-1902 (Pubitemid 29031005)
46. New AS, Hazlett EA, Buchsbaum MS, Goodman M, Mitelman SA, Newmark R, et al. Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology. 2007; 32: 1629-1640 (Pubitemid 46920160)
47. Nickel MK. Topiramate treatment of aggression in male borderline patients. Aust N Z J Psychiatry. 2007; 41: 461-462
48. Nickel MK, Nickel C, Kaplan P, Lahmann C, Muhlbacher M, Tritt K, et al. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biol Psychiatry. 2005; 57: 495-499 (Pubitemid 40311984)
49. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol. 1995; 51: 768-774 (Pubitemid 26021724)
50. Perucca E The Treatment of Epilepsy. Shorvon SD Fish D Perucca E Dodson WE, ed. Malden, MA: Blackwell; 2004 :
51. Paparrigopoulos T, Tzavellas E, Karaiskos D, Malitas P, Liappas I. An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects. J Psychopharmacol. 2010; 24: 1375-1380
52. Poshivalov VP. Pharmaco-ethological analysis of social behaviour of isolated mice. Pharmacol Biochem Behav. 1981; 14 (Suppl 1). 53-59 (Pubitemid 11138068)
53. Puglisi-Allegra S, Simler S, Kempf E, Mandel P. Involvement of the GABAergic system on shock-induced aggressive behavior in two strains of mice. Pharmacol Biochem Behav. 1981; 14 (Suppl 1). 13-18 (Pubitemid 11138061)
54. Rasmussen K, Levander S. Symptoms and personality characteristics of patients in a maximum security psychiatric unit. Int J Law Psychiatry. 1996; 19: 27-37 (Pubitemid 26079753)
55. Robins LN Mental Disorder and Crime. Hodgins S, ed. Newbury Park, CA: Sage; 1993 :
56. Saias T, Gallarda T. Paradoxical aggressive reactions to benzodiazepine use: a review. Encephale. 2008; 34: 330-336
57. Siever LJ. Neurobiology of aggression and violence. Am J Psychiatry. 2008; 165: 429-442 (Pubitemid 351694285)
58. Siegel A, Roeling TA, Gregg TR, Kruk MR. Neuropharmacology of brain-stimulation-evoked aggression. Neurosci Biobehav Rev. 1999; 23: 359-389 (Pubitemid 29053212)
59. Sorgi P, Ratey JJ, Knoedler DW, Markert RJ, Reichman M. Rating aggression in the clinical setting: a retrospective adaptation of the overt aggression scale. J Neuropsychiatry Clin Neurosci. 1991; 3: S52 - S56
60. Spielberger CD, Jacobs G, Russell S, Crane RS, Butcher JN, Spielberger CD Assessment of Anger: The State-Trait Anger Scale, Advances in Personality Assessment. Hillsdale, NJ: Erlbaum; 1983 :
61. Stanford MS, Anderson NE, Lake SL, Baldridge RM. Pharmacologic treatment of impulsive aggression with antiepileptic drugs. Curr Treat Options Neurol. 2009; 11: 383-390
62. Stanford MS, Helfritz LE, Conklin SM, Villemarette-Pittman NR, Greve KW, Adams D, et al. A comparison of anticonvulsants in the treatment of impulsive aggression. Exp Clin Psychopharmacol. 2005; 13: 72-77 (Pubitemid 40261832)
63. Steadman HJ, Mulvey EP, Monahan J, Robbins PC, Appelbaum PS, Grisso T, et al. Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Arch Gen Psychiatry. 1998; 55: 393-401 (Pubitemid 28237272)
64. Swanson JW, Holzer CE, 3rd, Ganju VK, Jono RT. Violence and psychiatric disorder in the community: evidence from the epidemiologic catchment area surveys. Hosp Community Psychiatry. 1990; 41: 761-770 (Pubitemid 20244681)
65. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993; 14: 169-177 (Pubitemid 23157765)
66. Wijeysundera DN, Austin PC, Hux JE, Beattie WS, Laupacis A. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. J Clin Epidemiology. 2009; 62: 13-21
67. Winhusen T, Somoza E, Ciraulo DA, Harrer JM, Goldsmith RJ, Grabowski J, et al. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. Drug Alcohol Depend. 2007; 91: 141-148 (Pubitemid 47554604)
68. Zachary RA Shipley Institute of Living Scale: Revised Manual. Los Angeles: Western Psychological Services; 1986 :